ITRM
Iterum Therapeutics plc
Key Financials
Net Income
$-24774000
↑ 35.4%
Total Assets
$44.6M
↑ 69.8%
EPS (Diluted)
$-1.26
↑ 57.4%
Revenue
$0
NaN%
Total Liabilities
$48.7M
↑ 49.0%
Operating Income
$-18696000
↑ 60.6%
Shareholders' Equity
$-4081000.00
↑ 36.3%
Long-term Debt
$31.2M
↑ 178.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 25-NSE | 6/23/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 8-K | 2/18/2026 | View on SEC |
| DEFA14A | 2/13/2026 | View on SEC |
| DEFA14A | 1/26/2026 | View on SEC |
| DEF 14A | 1/2/2026 | View on SEC |
| PRE 14A | 12/23/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ITRM |
| Company Name | Iterum Therapeutics plc |
| CIK | 1659323 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | L2 |
| Phone | (872) 225-6077 |